Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection-Reference-Cited by-同舟云学术

Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection

Published:2016-06 Issue: Volume:40 Page:24-35
ISSN:0952-7915
Container-title:Current Opinion in Immunology
language:en
Short-container-title:Current Opinion in Immunology

Author:

Zhukovsky Eugene A,Morse Richard J,Maus Marcela V^ORCID

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference111 articles.

1. Contribution to the knowledge of sarcoma;Coley;Ann Surg,1891

2. Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer;Eskander;Clin Pharmacol,2013

3. Utilizing the BiTE (bispecific T-cell engager) platform for immunotherapy of cancer;Stieglmaier;Expert Opin Biol Ther,2015

4. Alternative molecular formats and therapeutic applications for bispecific antibodies;Spiess;Mol Immunol,2015

5. Bispecific antibodies;Kontermann;Drug Discov Today,2015

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD28 co-stimulation: novel insights and applications in cancer immunotherapy;Nature Reviews Immunology;2024-07-25

2. Double hit — bispecific antibodies in cancer therapy;Oncology in Clinical Practice;2024-05-31

3. CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy;Blood;2024-05-23

4. Targeting CEACAM5-positive solid tumors using NILK-2401, a novel CEACAM5xCD47 κλ bispecific antibody;Frontiers in Immunology;2024-04-24

5. Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL;Leukemia;2023-08-26